TrialThe Journal of clinical endocrinology and metabolism2014

Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.

Philippe J Caron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.